GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
3i Infotech Ltd
3i Infotech Ltd: Board approves Rs. 13.11 crore subsidiary fund infusion & Q1 FY27 results
FUNDRAISE ▲ Positive Development LOW RISK
📅 Filed on BSE: 23 Jul 2026, 08:54 PM IST  ·  BSE ID: 4f87ab54-d7b8-4162-81f0-3603febdfe57
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board approved its latest quarterly financial results and a Rs. 13.11 crore funding plan for its subsidiary.
🤖 AI Summary
  • 3i Infotech board approved Rs. 11.11 crore loan conversion to preference shares.
  • Company is infusing additional Rs. 2 crore into subsidiary NuRe FutureTech.
  • Unaudited financial results for the quarter ended June 30, 2026 were approved.
  • Mr. Sanjay Vatsa appointed as Additional Director; Mr. Ambarish Dasgupta to retire.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Loan conversion to preference shares
Rs. 11.11 crore
Fresh fund infusion
Rs. 2 crore
Total capitalization of NuRe FutureTech
Rs. 13.11 crore
Quarter ended
June 30, 2026
33rd AGM date
August 28, 2026
🏢 How This Affects the Company
📈
Business Impact
The infusion of Rs. 13.11 crore into NuRe FutureTech Private Limited strengthens the subsidiary's capital base, facilitating its operations and potential growth within its domain.
💰
Financial Impact
The conversion of loan to redeemable preference shares and fresh equity infusion will reconfigure the balance sheet of both 3i Infotech and its subsidiary, impacting debt-equity ratios.
⚙️
Operational Impact
Appointment of Mr. Sanjay Vatsa as Additional Director and Mr. Venu Gopal Reddy as Senior Management Personnel brings new leadership perspectives and domain expertise.
⚠️
Risk Impact
The retirement of Mr. Ambarish Dasgupta due to potential conflict of interest mitigates a specific business risk by ensuring adherence to ethical standards and avoiding overlap.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders concerning the financial results or subsidiary funding. Shareholders should note the upcoming 33rd AGM for director appointments.
👤
Who Is Affected
All shareholders are affected by the company's financial performance as reported in the unaudited results. Shareholders will vote on director appointments at the AGM.
🔍
Management Signal
Management is focused on strengthening subsidiary operations through capital infusion and ensuring governance through timely director transitions and adherence to regulations.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
33rd AGM proceedings for director appointment approvals.
NuRe FutureTech's performance post-capital infusion.
Detailed Q2 FY27 financial results release.
LOW RISK Routine financial reporting and standard subsidiary funding are low-risk events.
💡 Investor Takeaway
3i Infotech approved Rs. 13.11 crore capitalization for its subsidiary, NuRe FutureTech, through loan conversion and fresh infusion. Unaudited results for Q1 FY27 were also approved.
⚖️ Strengths & Concerns

✅ Positives

  • Rs. 13.11 crore total capitalisation for subsidiary NuRe FutureTech through loan conversion and fund infusion.
  • Approval of unaudited financial results for the quarter ended June 30, 2026, providing recent performance data.
❓ Frequently Asked Questions
What is the total amount 3i Infotech is infusing into NuRe FutureTech Private Limited?
3i Infotech is converting Rs. 11.11 crore loan and infusing Rs. 2 crore, making a total capitalization of Rs. 13.11 crore.
What financial period did 3i Infotech's board approve results for?
The Board of Directors approved the unaudited financial results for the quarter ended June 30, 2026.
When is the 33rd Annual General Meeting (AGM) of 3i Infotech scheduled?
The 33rd AGM of 3i Infotech is scheduled to be convened on Friday, August 28, 2026.
Who has been appointed as a new director at 3i Infotech?
Mr. Sanjay Vatsa has been approved by the Board as an Additional Director, subject to shareholder approval at the AGM.
Why is Mr. Ambarish Dasgupta retiring from the board of 3i Infotech?
Mr. Ambarish Dasgupta is retiring as he expressed his intention not to seek re-appointment due to potential conflict of interest with his firm's IT domain expansion.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.